SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Cannabis > Therapix Biosciences Ltd. ADR (THXBY)

THXBY one for 2 reverse split: (closing PPS $4.01)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Renee Member Profile
Member Level 
Followed By 1,177
Posts 24,335
Boards Moderated 10
Alias Born 07/12/04
160x600 placeholder
Therapix Biosciences and Assuta Medical Center to Initiate Clinical Trial in Obstructive Sleep Apnea "PR Newswire (US)" - 10/18/2017 8:30:00 AM
Therapix Signs Formulation Development and Clinical Manufacturing Agreement with Catalent for THX-TS01 "PR Newswire (US)" - 10/6/2017 8:30:00 AM
Therapix's First-in-Class Therapy Demonstrates Reversal of Age-Related Cognitive Impairment in Pre-Clinical Study "PR Newswire (US)" - 9/27/2017 8:30:00 AM
Therapix Biosciences Reports Second Quarter 2017 Financial Results and Provides Business Update "PR Newswire (US)" - 8/10/2017 8:00:00 AM
Therapix Biosciences Second Quarter 2017 Conference Call and Webcast Scheduled for Thursday, August 10, 2017 "PR Newswire (US)" - 8/3/2017 8:30:00 AM
CURE Pharmaceutical & Therapix Biosciences Signs MOU with Israel’s Assuta Medical Centers to Develop First-in-Class Therape... "GlobeNewswire Inc." - 7/11/2017 9:00:00 AM
CURE Pharmaceutical & Therapix Biosciences Signs MOU with Israel's Assuta Medical Center to Develop First-in-Class Therapeuti... "PR Newswire (US)" - 7/11/2017 8:00:00 AM
Therapix Biosciences to Ring the Nasdaq Stock Market Opening Bell on June 28 "PR Newswire (US)" - 6/27/2017 4:15:00 PM
Therapix Biosciences Ltd. (Nasdaq: TRPX) to Ring The Nasdaq Stock Market Opening Bell "GlobeNewswire Inc." - 6/27/2017 10:00:00 AM
Therapix Biosciences to Present at Upcoming Scientific and Investor Conferences in June "PR Newswire (US)" - 5/30/2017 8:24:00 AM
Therapix Biosciences Announces CEO Change "PR Newswire (US)" - 5/24/2017 5:40:00 PM
Therapix Biosciences and the Hannover Medical School Enter into an Investigator-initiated Clinical Trial Agreement to Assess ... "PR Newswire (US)" - 5/8/2017 8:30:00 AM
Therapix Biosciences Announces the Appointment of Josh Blacher as Chief Financial Officer "PR Newswire (US)" - 5/3/2017 8:30:00 AM
Therapix Signs Exclusive License Agreement with Yissum for Nasal Drug Delivery Technology "PR Newswire (US)" - 4/5/2017 8:55:00 AM
Therapix Biosciences Ltd. Announces Full Exercise of Underwriters' Over-Allotment Option "PR Newswire (US)" - 4/3/2017 4:01:00 PM
Therapix Biosciences Ltd. Announces Closing of U.S. Initial Public Offering of American Depositary Shares; 2,000,000 American... "PR Newswire (US)" - 3/27/2017 4:43:00 PM
Therapix Biosciences Ltd. Announces Pricing of U.S. Initial Public Offering and NASDAQ Listing "PR Newswire (US)" - 3/22/2017 4:06:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist